Novavax Inc

NVAX:NASDAQ
RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 11:30 AM EST
128.72quote price arrow down-2.74 (-2.08%)
Volume
1,107,382
52 week range
6.26 - 189.40

...

Loading . . .

KEY STATS

  • Open131.61
  • Day High132.47
  • Day Low128.19
  • Prev Close131.46
  • 52 Week High189.40
  • 52 Week High Date08/05/20
  • 52 Week Low6.26
  • 52 Week Low Date02/07/20
  • Market Cap8,194.32M
  • Shares Out63.66M
  • 10 Day Average Volume3.42M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • 1 Year % Change1,564.1

RATIOS/PROFITABILITY

  • EPS (TTM)-5.22
  • P/E (TTM)-24.67
  • Fwd P/E (NTM)15.41
  • EBITDA (MRQ)-262.45M
  • ROE (MRQ)-829.23%
  • Revenue (MRQ)204.76M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-133.10%
  • Debt To Equity (MRQ)143.88%

EVENTS

  • Earnings Date03/15/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest NVAX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Related Video

VIDEO1:1901:19
Novavax begins phase three trial for Covid vaccine

Profile

MORE
Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. The Company's product pipeline focuses on a range of infectious diseases with vaccine candidates...
James Young Ph.D.
Chairman
Stanley Erck
President
Rick Crowley
Chief Operating Officer
Gregory Covino
Chief Financial Officer
Ben Machielse
Executive Vice President
Address
21 Firstfield Rd
Gaithersburg, MD
20878-1757
United States